Sfoglia per Autore
Long-term protective effects of the angiotensin receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress and myocardial dysfunction
2011-01-01 Dessi, M; Piras, A; Madeddu, Clelia; CADEDDU DESSALVI, Christian; Deidda, Martino; Massa, Elena; Antoni, G; Mantovani, G; Mercuro, Giuseppe
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
2011-01-01 Regan, Mm; Neven, P; Giobbie-Hurder, A; Goldhirsch, A; Ejlertsen, B; Mauriac, L; Forbes, Jf; Smith, I; Láng, I; Wardley, A; Rabaglio, M; Price, Kn; Gelber, Rd; Coates, As; Thürlimann, B; Massa, E
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia
2010-01-01 Madeddu, Clelia; Macciò, Antonio; Astara, G; Massa, Elena; Dessì, M; Antoni, Giorgia; Panzone, F; Serpe, Roberto; Mantovani, Giovanni
Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens
2010-01-01 Massa, Elena; Dessi, M; Gaspardini, G; Saba, F; Cherchi, V; Mantovani, G.
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia
2010-01-01 Mantovani, G; Maccio', A; Madeddu, Clelia; Serpe, Roberto; Antoni, G; Massa, Elena; Dessi', Mariele; Panzone, F.
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS)
2010-01-01 Madeddu, Clelia; Macciò, A; Panzone, F; Serpe, Roberto; Dessi, M; Massa, E; Mantovani, G.
Cardioprotective effect of telmisartan in cancer patients treated with telmisartan
2010-01-01 Dessi, M; Madeddu, Clelia; Serpe, Roberto; Massa, Elena; CADEDDU DESSALVI, Christian; Piras, A; Mercuro, Giuseppe; Mantovani, G.
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia
2010-01-01 Mantovani, G; Maccio, A; Madeddu, Clelia; Serpe, Roberto; Massa, Elena; Dessi', Mariele; Panzone, F; Contu, Paolo
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin.
2010-01-01 Dessi, M.; Madeddu, Clelia; Antoni, G.; Massa, Elena; CADEDDU DESSALVI, Christian; Piras, A.; Deidda, Martino; Mercuro, Giuseppe; Mantovani, G.
Long Term Effects of Telmisartan on the Inflammation, Oxidative Stress and Myocardial Impairment Induced by Epirubucin
2010-01-01 Piras, A; CADEDDU DESSALVI, Christian; Dessì, M; Binaghi, G; Deidda, Martino; Massa, Elena; Madeddu, Clelia; Mantovani, G; Mercuro, Giuseppe
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment
2010-01-01 CADEDDU DESSALVI, Christian; Piras, A; Mantovani, G; Deidda, Martino; Dessì, M; Madeddu, Clelia; Massa, Elena; Mercuro, Giuseppe
Risultati preliminari di uno studio di fase II con Sorafenib in pazienti anziani affetti da epatocarcinoma
2009-01-01 Massa, E; Chessa, Luchino; Madeddu, Clelia; Zolfino, T; Liguori, S; Marini, S; Dessi', Mariele; Mantovani, G.
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer
2009-01-01 Giobbie-Hurder, A; Price, Kn; Gelber, Rd; Mantovani, G; Massa, E; on behalf of International Breast Cancer Study, Group; BIG 1-98 Collaborative Group. Clin Trials., 2009 Jun; 6(3):272-87,
Preliminary data on a cardioprotective effect of telmisartan in cancer patients treated with epirubicin
2009-01-01 Piras, A.; CADEDDU DESSALVI, Christian; Dessi, M.; Deidda, Martino; Binaghi, G.; Madeddu, Clelia; Massa, E.; Mantovani, G.; Mercuro, Giuseppe
Efficacy, safety and impact on quality of life of a treatment with sorafenib in elderly cancer patients with advanced hepatocellular carcinoma. Preliminary results of a phase II study
2009-01-01 Mantovani, G; Massa, E; Spiga, C; Chessa, Luchino; Zolfino, T; Piras, R; Madeddu, Clelia; Lepori, S; Serra, G; Marini, S.
Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: Comparison between elderly and non-elderly patient response
2009-01-01 Massa, Elena; Astara, G; Madeddu, Clelia; Dessi, M; Loi, C; Lepori, S; Mantovani, G.
Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients
2009-01-01 Bozzetti, F; Mantovani, G; Massa, E; Madeddu, C; ON BEHALF OF THE SCRINIO, Group
New perspective on the nutritional approach to cancer-related anorexia/cachexia: Preliminary results of a randomised phase III clinical trial with five different arms of treatment
2009-01-01 Tanca, Fm; Madeddu, Clelia; Macciò, A; Serpe, R; Panzone, F; Antoni, G; Massa, Elena; Astara, A; Mantovan, G.
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer
2009-01-01 Mouridsen, H; Giobbie-Hurder, A; Goldhirsch, A; Thürlimann, B; Paridaens, R; Smith, I; Mauriac, L; Forbes, Jf; Price, Kn; Regan, Mm; Gelber, Rd; Coates, As; Mantovani, G; Massa, E; on behalf of BIG 1-98 Collaborative, Group
Efficacy, safety and impact on quality of life of Sorafenib in elderly patients with advanced Hepatocellular carcinoma. Preliminary results of a Phase II study
2009-01-01 Mantovani, G; Massa, E; Spiga, C; Chessa, Luchino; Madeddu, Clelia; Zolfino, T; Lepori, S; Serra, G; Piras, Mr; Marini, S.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile